Results 151 to 160 of about 56,738 (264)

Late Presentation of de Novo Proliferative Glomerulonephritis With Monoclonal IgG Deposits in a Renal Allograft: A Rare Case With an Unusual Clinical Course

Nephrology, Volume 31, Issue 6, June 2026.
ABSTRACT Proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID) is a form of monoclonal gammopathy of renal significance (MGRS) in which monoclonal immunoglobulin deposits are found within the glomerulus, without involvement of other renal compartments.
Hayley J. Duxbury, David A. Brown, Adrian Y. S. Lee, Germaine Wong, Fiona Kwok, Seethalakshmi Viswanathan   +5 more
wiley   +1 more source

Nailfold video capillaroscopy in patients with suspected systemic sclerosis: a comparison of one-finger method versus eight-finger method. [PDF]

J Scleroderma Relat Disord
Doornewaard L, Haverkort D, Kersten BE, Vonk MC.   +3 more
europepmc   +1 more source

Scleroderma Clinical Trials Consortium (SCTC) outcome instruments for evaluation of systemic sclerosis. [PDF]

J Scleroderma Relat Disord
Valenzuela A, Chung L, Pauling JD, Domsic R, Saketkoo L, Fligelstone K, Russell AM, Khanna D, Frech T, Ross L, Nikpour M, Denton C, Baron M.   +12 more
europepmc   +1 more source

Prevalence, Incidence, and Mortality of Raynaud’s phenomenon, Sjögren’s syndrome, and scleroderma: an umbrella review of systematic reviews

Objectives: To comprehensively review systematic reviews of prevalence, incidence, and mortality of Raynaud’s, Sjögren’s, and Scleroderma, and to identify any research gaps.Methods: An umbrella review of English language systematic reviews was undertaken
Chen, Anthony, Pearce, Fiona A, Lanyon, Peter C, Lax, Stephanie J, Grainge, Matthew J   +4 more
core   +1 more source

Knowledge and perceptions of medical practitioners on the role of nutrition in systemic sclerosis. [PDF]

J Scleroderma Relat Disord
Efthymiou E, Pardali EC, Gkouvi A, Mitropoulos A, Katsiari CG, Koidou E, Goulis DG, Klonizakis M, Bogdanos DP, Grammatikopoulou MG.   +9 more
europepmc   +1 more source

ANA negative scleroderma

, 2018
Background Systemic Sclerosis (SSc) is an autoimmune disease characterized by inflammation, fibrosis, and vasculopathy. More than 90% of patients with SSc test positive for anti-nuclear antibodies using immunofluorescence (IF-ANA) as well as for ...
Haj-Ali, Mayce, Shanmugam, Victoria K, Jones, Derek, McNish, Sean   +3 more
core  

Immune Checkpoint Inhibitor-Induced Scleroderma-Like Pulmonary Fibrosis in a Patient With Advanced Lung Cancer: A Case Report. [PDF]

Cureus
Rodriguez Padilla JO, Kheti Y, Carrillo F, Villacreses C.   +3 more
europepmc   +1 more source

Are we ready to predict progressive disease in juvenile systemic sclerosis? [PDF]

J Scleroderma Relat Disord
Foeldvari I, Klotsche J, Torok KS.
europepmc   +1 more source

Palliative care in systemic sclerosis: incorporating advance care planning into longitudinal care. [PDF]

J Scleroderma Relat Disord
Savoie MB, Logeman JL, Castelino FV.
europepmc   +1 more source

Intrauterine stroke from a sword on the face - A rare diagnosis and its long-term sequelae. [PDF]

Indian J Ophthalmol
Kumar J, Agrawal S, Pushker N.
europepmc   +1 more source